Cyclopharm Bell Potter Healthcare Conference Presentation
Filed with ASX · · 40 pages · English and French
In the deck
Story so far
Earlier from Cyclopharm
- Legal Proceedings
- S&P DJI Announces September 2025 Quarterly Rebalance
- CYC 1H2025 Results Summary
- Half Yearly Report and Accounts
- Cyclopharm Secures Maximum US Patent Extension for Technegas
Later from Cyclopharm
- Colombia Approval Marks 67th Country for Technegas
- Stanford Children's Health to Implement Technegas
- Insurer Indemnifies Cyclopharm
- Technegas Recognised in Updated Clinical Guideline
- COPD Study Leveraging Technegas and AI-Driven Lung Analysis
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm